The goal of this randomized controlled trial is to assess the extent to which different modes of contacting parents who have not yet enabled to access to their children's medical records will result in greater proxy access. The main questions the study aims to answer are: * will outreach via text or patient portal message result in more parents having access than usual care (which is in-office suggestions to get access). * which mode - text or portal - will get more parents access. Participants will get a text message, or a portal message through their own patient portal, or no message. The investigators will check access to see which group has increased more during the study period.
Health Technology
The goal of this randomized controlled trial is to assess the extent to which different modes of contacting parents who have not yet enabled to access to their children's medical records will result in greater proxy access. The main questions the study aims to answer are: * will outreach via text or patient portal message result in more parents having access than usual care (which is in-office suggestions to get access). * which mode - text or portal - will get more parents access. Participants will get a text message, or a portal message through their own patient portal, or no message. The investigators will check access to see which group has increased more during the study period.
MyChart Proxy Outreach to Parents (MyPOP)
-
Cornell Scott Hill Health Center, New Haven, Connecticut, United States, 06511
Fair Haven Community Health Center, New Haven, Connecticut, United States, 06513
Yale New Haven Health, New Haven, Connecticut, United States, 06520
Yale School of Medicine, New Haven, Connecticut, United States, 06520
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
Yes
Yale University,
Ada Fenick, MD, PRINCIPAL_INVESTIGATOR, Yale University
2025-01